For the Inventor, By the Inventor

Enter assignee name

Intron Biotechnology, Inc.

USPTO Granted Patents = 69

EPO Patents = 9

Trademarks = 6

Forward Citations = 96

Loading Chart...

Loading Chart...

83 inventors (with patents filed for the assignee):

Seong Jun Yoon (47 out of 48 patents)

SAng Hyeon Kang (46 out of 71 patents)

Soo Youn Jun (45 out of 46 patents)

4. Jee Soo Son (25 out of 25 patents)

5. Hyoun Rok Paik (18 out of 18 patents)

6. Seongjun Yoon (14 out of 14 patents)

7. Sanghyeon Kang (14 out of 14 patents)

8. An Sung Kwon (12 out of 13 patents)

9. Sooyoun Jun (9 out of 9 patents)

10. Soon Hye Hwang (8 out of 8 patents)

11. Jeesoo Son (8 out of 8 patents)

12. Hyoung Rok Paik (7 out of 7 patents)

13. Yunjaie Choi (7 out of 7 patents)

14. In Hwang Kim (7 out of 7 patents)

15. Hee Jeong Shin (7 out of 7 patents)

Core Competencies:

Antibacterial Protein

Bacteriophage

Magnetic Resonance Imaging

Peptide Compound

Heme Iron

Enterotoxigenic Bacteria

Pathogenic Inhibition

Gram Negative Infections

PCR Primer

Intracellular Expression

Nanoparticle Contrast Agent

Neuroprotective Composition

69 patents: Sort by Forward Citations

1. 12503494 - ANTIBACTERIAL PROTEIN CDL200 HAVING LYTIC ACTIVITY AGAINST CLOSTRIDIOIDES DIFFICILE (2025-12-23),

2. 12358953 - Antibacterial protein having lytic activity togenus and method for preparing the same (2025-07-15),

3. 12280081 - Compositions and methods for inhibiting the proliferation of enterotoxigenic (2025-04-21),

4. 12274721 - Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis (2025-04-14),

5. 12263196 - Compositions and methods for inhibiting the proliferation of enterotoxigenic (2025-04-01),

6. 12114664 - bacteriophage STP-2 and use thereof for inhibiting proliferation of (2024-10-15),

7. 11970700 - Genetic element E3 for enhanced intracellular expression of target protein encoded in RNA therapeutics (2024-04-30),

8. 11701398 - Compositions and methods for inhibiting the proliferation of pathogenic (2023-07-18),

9. 11679138 - Vibrio parahaemolyticus bacteriophage Vib-PAP-7 and use of same for inhibiting vibrio parahaemolyticus bacteria proliferation (2023-06-20),

10. 11679137 - bacteriophage Vib-PAP-4 and use thereof in inhibiting proliferation ofbacteria (2023-06-20),

11. 11596659 - Compositions and methods for inhibiting the proliferation of pathogenic (2023-03-07),

12. 11583565 - Compositions and methods for inhibiting the proliferation of pathogenic (2023-02-21),

13. 11548917 - Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same (2023-01-10),

14. 11529406 - bacteriophage Clo-PEP-2 and use for inhibitingproliferation of same (2022-12-20),

15. 11497216 - bacteriophage pse-AEP-4 and use thereof for inhibiting proliferation of (2022-11-15),

INTRON BIOTECHNOLOGY, INC. is a leading biotechnology company that specializes in research, development, and production of innovative solutions in the field of biotechnology. With decades of experience, INTRON BIOTECHNOLOGY is dedicated to advancing scientific discoveries and developing products that improve human health and the environment. Visit their website to learn more about their cutting-edge research and wide range of biotechnology offerings.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

69 Patents

#17 in

#127 in

#10,499 in the World

Intron Biotechnology, Inc.

Forward Citations = 96

83 inventors:

Seong Jun Yoon (47 out of 48 patents)

SAng Hyeon Kang (46 out of 71 patents)

Soo Youn Jun (45 out of 46 patents)

4. Jee Soo Son (25 out of 25 patents)

5. Hyoun Rok Paik (18 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…